DGX Quest Diagnostics
NYSE · SEC CIK 1022079 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $37.31M 23 sales by 8 insiders
- Filings on record
- 341 since 2021-07-06, latest 2026-09-03 17:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Davis J. E. | CEO, Pres, Dir | — | $17.08M |
| Doherty Catherine T. | EVP, Regional Businesses | — | $6.96M |
| PREVOZNIK MICHAEL E | SVP, GC | — | $6.69M |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | — | $2.17M |
| Plewman Patrick | SVP for Diagnostic Services | — | $2.03M |
| DELANEY MARK E | SVP, Chief Commercial Off | — | $1.86M |
| PFEIFFER GARY M | Dir | — | $270.3K |
| Gregg Vicky B | Dir | — | $239.7K |
| Lassiter Wright III | Dir | — | — |
| Deppe Michael J | SVP, CAO, Corp. Ctrl | — | — |
Transactions 434
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-19 | 2023-05-17 | DGX | WILENSKY GAIL R | Dir | A - Grant | $0.00 | +1,369 | 20.5K | +7% | $0 | |
| 2023-05-19 | 2023-05-17 | DGX | PFEIFFER GARY M | Dir | A - Grant | $0.00 | +1,369 | 26.8K | +5% | $0 | |
| 2023-05-19 | 2023-05-17 | DGX | MAIN TIMOTHY L | Dir | A - Grant | $0.00 | +1,369 | 23.6K | +6% | $0 | |
| 2023-05-19 | 2023-05-17 | DGX | Diaz Luis | Dir | A - Grant | $0.00 | +1,369 | 1,369 | New | $0 | |
| 2023-05-19 | 2023-05-17 | DGX | Doi Tracey | Dir | A - Grant | $0.00 | +1,369 | 3,621 | +61% | $0 | |
| 2023-04-25 | 2023-04-24 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L - Small Acq | $143.08 | +25 | 11.3K | +0.2% | +$3,577 | |
| 2023-04-25 | 2023-04-24 | DGX | Plewman Patrick | SVP for Diagnostic Services | L - Small Acq | $143.08 | +44 | 12.3K | +0.4% | +$6,296 | |
| 2023-04-25 | 2023-04-24 | DGX | Gregg Vicky B | Dir | L - Small Acq | $143.08 | +72 | 17.2K | +0.4% | +$10.3K | |
| 2023-03-27 | 2023-03-24 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $134.25 | -170 | 3,480 | -5% | -$22.8K | |
| 2023-03-27 | 2023-03-24 | DGX | Plewman Patrick | SVP for Diagnostic Services | F - Tax | $134.25 | -99 | 12.3K | -0.8% | -$13.3K | |
| 2023-03-08 | 2023-03-06 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - Grant | $147.86 | +1,985 | 11.8K | +20% | +$293.5K | |
| 2023-03-08 | 2023-03-06 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F - Tax | $147.86 | -583 | 11.2K | -5% | -$86.2K | |
| 2023-03-08 | 2023-03-06 | DGX | DEPPE MICHAEL J | SVP, CAO, Corp. Ctrl | F - Tax | $147.86 | -682 | 33.5K | -2% | -$100.8K | |
| 2023-03-08 | 2023-03-06 | DGX | DEPPE MICHAEL J | SVP, CAO, Corp. Ctrl | A - Grant | $147.86 | +1,918 | 34.2K | +6% | +$283.6K | |
| 2023-03-08 | 2023-03-06 | DGX | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $147.86 | +8,595 | 47.1K | +22% | +$1.27M | |
| 2023-03-08 | 2023-03-07 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $140.55 | -4,754 | 38.5K | -11% | -$668.2K | |
| 2023-03-08 | 2023-03-06 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $147.86 | -3,841 | 43.3K | -8% | -$567.9K | |
| 2023-03-08 | 2023-03-06 | DGX | Plewman Patrick | SVP for Diagnostic Services | F - Tax | $147.86 | -799 | 12.4K | -6% | -$118.1K | |
| 2023-03-08 | 2023-03-06 | DGX | Plewman Patrick | SVP for Diagnostic Services | A - Grant | $147.86 | +2,579 | 13.1K | +24% | +$381.3K | |
| 2023-03-08 | 2023-03-06 | DGX | Davis J. E. | CEO, Pres, Dir | A - Grant | $147.86 | +15.2K | 110.7K | +16% | +$2.25M | |
| 2023-03-08 | 2023-03-06 | DGX | Davis J. E. | CEO, Pres, Dir | F - Tax | $147.86 | -8,036 | 102.6K | -7% | -$1.19M | |
| 2023-03-08 | 2023-03-06 | DGX | Doherty Catherine T. | SVP, Regional Businesses | A - Grant | $147.86 | +9,917 | 77.7K | +15% | +$1.47M | |
| 2023-03-08 | 2023-03-07 | DGX | Doherty Catherine T. | SVP, Regional Businesses | S - Sale | $140.55 | -5,307 | 67.8K | -7% | -$745.9K | |
| 2023-03-08 | 2023-03-06 | DGX | Doherty Catherine T. | SVP, Regional Businesses | F - Tax | $147.86 | -4,610 | 73.1K | -6% | -$681.6K | |
| 2023-03-08 | 2023-03-06 | DGX | RUSCKOWSKI STEPHEN H | Dir | A - Grant | $147.86 | +82.6K | 428.2K | +24% | +$12.22M | |
| 2023-03-08 | 2023-03-06 | DGX | RUSCKOWSKI STEPHEN H | Dir | F - Tax | $147.86 | -38.6K | 389.6K | -9% | -$5.71M | |
| 2023-03-06 | 2023-03-03 | DGX | Doherty Catherine T. | SVP, Regional Businesses | S - Sale | $140.63 | -717 | 67.8K | -1% | -$100.8K | |
| 2023-03-03 | 2023-03-01 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $140.69 | -320 | 39.1K | -0.8% | -$45.0K | |
| 2023-03-03 | 2023-03-02 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $138.54 | -593 | 38.5K | -2% | -$82.2K | |
| 2023-03-03 | 2023-03-01 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F - Tax | $140.69 | -65 | 9,839 | -0.7% | -$9,145 | |
| 2023-03-03 | 2023-03-01 | DGX | RUSCKOWSKI STEPHEN H | Dir | F - Tax | $140.69 | -3,496 | 345.6K | -1% | -$491.9K | |
| 2023-03-03 | 2023-03-01 | DGX | Plewman Patrick | SVP for Diagnostic Services | F - Tax | $140.69 | -90 | 10.6K | -0.8% | -$12.7K | |
| 2023-03-03 | 2023-03-01 | DGX | Davis J. E. | CEO, Pres, Dir | F - Tax | $140.69 | -1,292 | 95.5K | -1% | -$181.8K | |
| 2023-03-03 | 2023-03-01 | DGX | DEPPE MICHAEL J | SVP, CAO, Corp. Ctrl | F - Tax | $140.69 | -68 | 32.3K | -0.2% | -$9,567 | |
| 2023-03-03 | 2023-03-01 | DGX | Doherty Catherine T. | SVP, Regional Businesses | F - Tax | $140.69 | -392 | 68.5K | -0.6% | -$55.2K | |
| D | 2023-02-27 | 2023-02-23 | DGX | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $0.00 | +2,442 | 40.9K | +6% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $147.86 | -811 | 38.4K | -2% | -$119.9K |
| D | 2023-02-27 | 2023-02-24 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $141.42 | -1,415 | 39.4K | -3% | -$200.1K |
| D | 2023-02-27 | 2023-02-23 | DGX | Plewman Patrick | SVP for Diagnostic Services | A - Grant | $0.00 | +1,919 | 10.7K | +22% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | Plewman Patrick | SVP for Diagnostic Services | F - Tax | $147.86 | -245 | 8,737 | -3% | -$36.2K |
| D | 2023-02-27 | 2023-02-23 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | A - Grant | $0.00 | +1,919 | 3,650 | +111% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | SAMAD SAM | EVP, CFO | A - Grant | $0.00 | +4,710 | 20.4K | +30% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | Doherty Catherine T. | SVP, Regional Businesses | F - Tax | $147.86 | -962 | 66.8K | -1% | -$142.2K |
| D | 2023-02-27 | 2023-02-23 | DGX | Doherty Catherine T. | SVP, Regional Businesses | A - Grant | $0.00 | +3,838 | 70.6K | +6% | $0 |
| D | 2023-02-27 | 2023-02-24 | DGX | Doherty Catherine T. | SVP, Regional Businesses | S - Sale | $141.42 | -1,690 | 68.9K | -2% | -$239.0K |
| 2023-02-27 | 2023-02-23 | DGX | RUSCKOWSKI STEPHEN H | Dir | A - Grant | $0.00 | +20.1K | 349.1K | +6% | $0 | |
| 2023-02-27 | 2023-02-23 | DGX | RUSCKOWSKI STEPHEN H | Dir | F - Tax | $147.86 | -5,826 | 329.0K | -2% | -$861.4K | |
| D | 2023-02-27 | 2023-02-23 | DGX | DEPPE MICHAEL J | SVP, CAO, Corp. Ctrl | A - Grant | $0.00 | +498 | 32.3K | +2% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | DEPPE MICHAEL J | SVP, CAO, Corp. Ctrl | F - Tax | $147.86 | -188 | 31.8K | -0.6% | -$27.8K |
| D | 2023-02-27 | 2023-02-23 | DGX | GARDNER MARK A | SVP of Molecular Gen, Oncol | A - Grant | $0.00 | +1,919 | 2,921 | +192% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F - Tax | $147.86 | -195 | 7,810 | -2% | -$28.8K |
| D | 2023-02-27 | 2023-02-23 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - Grant | $0.00 | +2,094 | 9,904 | +27% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | Davis J. E. | CEO, Pres, Dir | A - Grant | $0.00 | +17.4K | 96.8K | +22% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | Davis J. E. | CEO, Pres, Dir | F - Tax | $147.86 | -1,473 | 79.3K | -2% | -$217.8K |
| 2023-02-03 | 2023-02-01 | DGX | Gregg Vicky B | Dir | L - Small Acq | $146.75 | +64 | 17.1K | +0.4% | +$9,392 | |
| 2023-02-03 | 2023-02-01 | DGX | Plewman Patrick | SVP for Diagnostic Services | L - Small Acq | $146.75 | +27 | 8,982 | +0.3% | +$3,962 | |
| 2023-02-03 | 2023-02-01 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L - Small Acq | $146.75 | +13 | 8,005 | +0.2% | +$1,908 | |
| DM | 2022-12-05 | 2022-12-01 | DGX | RING TIMOTHY M | Dir | M - OptEx | $57.39 | +2,025 | 25.1K | +9% | +$116.2K |
| D | 2022-12-05 | 2022-12-01 | DGX | RING TIMOTHY M | Dir | S - Sale+OE | $152.50 | -2,025 | 24.1K | -8% | -$308.8K |
| D | 2022-11-29 | 2022-11-28 | DGX | Doherty Catherine T. | SVP, Regional Businesses | M - OptEx | $86.63 | +40.8K | 108.5K | +60% | +$3.53M |
| DM | 2022-11-29 | 2022-11-28 | DGX | Doherty Catherine T. | SVP, Regional Businesses | S - Sale+OE | $149.18 | -40.8K | 91.1K | -31% | -$6.08M |
| 2022-11-03 | 2022-11-01 | DGX | Davis J. E. | CEO, Pres, Dir | A - Grant | $0.00 | +14.0K | 80.8K | +21% | $0 | |
| DM | 2022-11-02 | 2022-11-01 | DGX | RING TIMOTHY M | Dir | M - OptEx | $61.07 | +2,000 | 25.9K | +8% | +$122.1K |
| D | 2022-11-02 | 2022-11-01 | DGX | RING TIMOTHY M | Dir | S - Sale+OE | $144.06 | -2,000 | 24.1K | -8% | -$288.1K |
| DM | 2022-10-27 | 2022-10-26 | DGX | DEPPE MICHAEL J | VP, CAO, Corp. Ctrl | M - OptEx | $53.79 | +15.5K | 41.1K | +60% | +$833.6K |
| D | 2022-10-27 | 2022-10-26 | DGX | DEPPE MICHAEL J | VP, CAO, Corp. Ctrl | S - Sale+OE | $145.00 | -15.5K | 32.0K | -33% | -$2.25M |
| 2022-10-21 | 2022-10-19 | DGX | Gregg Vicky B | Dir | L - Small Acq | $127.67 | +74 | 17.1K | +0.4% | +$9,448 | |
| D | 2022-10-04 | 2022-10-03 | DGX | RING TIMOTHY M | Dir | M - OptEx | $61.23 | +2,000 | 25.9K | +8% | +$122.5K |
| D | 2022-10-04 | 2022-10-03 | DGX | RING TIMOTHY M | Dir | S - Sale+OE | $123.39 | -2,000 | 23.9K | -8% | -$246.8K |
| D | 2022-09-06 | 2022-09-01 | DGX | RING TIMOTHY M | Dir | S - Sale+OE | $125.02 | -2,000 | 23.9K | -8% | -$250.0K |
| D | 2022-09-06 | 2022-09-01 | DGX | RING TIMOTHY M | Dir | M - OptEx | $61.23 | +2,000 | 25.9K | +8% | +$122.5K |
| DM | 2022-08-02 | 2022-08-01 | DGX | RING TIMOTHY M | Dir | M - OptEx | $60.86 | +2,000 | 25.9K | +8% | +$121.7K |
| D | 2022-08-02 | 2022-08-01 | DGX | RING TIMOTHY M | Dir | S - Sale+OE | $136.04 | -2,000 | 23.9K | -8% | -$272.1K |
| 2022-07-21 | 2022-07-20 | DGX | Gregg Vicky B | Dir | L - Small Acq | $134.47 | +70 | 17.0K | +0.4% | +$9,413 | |
| DM | 2022-07-05 | 2022-07-01 | DGX | RING TIMOTHY M | Dir | M - OptEx | $57.46 | +2,000 | 24.9K | +9% | +$114.9K |
| D | 2022-07-05 | 2022-07-01 | DGX | RING TIMOTHY M | Dir | S - Sale+OE | $133.47 | -2,000 | 23.9K | -8% | -$266.9K |
| DM | 2022-05-26 | 2022-05-25 | DGX | RUSCKOWSKI STEPHEN H | COB, CEO, Pres, Dir | S - Sale+OE | $140.89 | -24.9K | 338.0K | -7% | -$3.51M |
| DM | 2022-05-26 | 2022-05-25 | DGX | RUSCKOWSKI STEPHEN H | COB, CEO, Pres, Dir | M - OptEx | $93.46 | +24.9K | 344.9K | +8% | +$2.33M |
| DM | 2022-05-25 | 2022-05-23+ | DGX | RUSCKOWSKI STEPHEN H | COB, CEO, Pres, Dir | S - Sale+OE | $140.13 | -359.9K | 335.0K | -52% | -$50.43M |
| DM | 2022-05-25 | 2022-05-23+ | DGX | RUSCKOWSKI STEPHEN H | COB, CEO, Pres, Dir | M - OptEx | $94.21 | +359.9K | 369.7K | +3,651% | +$33.90M |
| 2022-05-20 | 2022-05-18 | DGX | PFEIFFER GARY M | Dir | A - Grant | $0.00 | +1,292 | 25.0K | +5% | $0 | |
| 2022-05-20 | 2022-05-18 | DGX | Gregg Vicky B | Dir | A - Grant | $0.00 | +1,292 | 16.9K | +8% | $0 | |
| 2022-05-20 | 2022-04-18 | DGX | Gregg Vicky B | Dir | L - Small Acq | $134.88 | +61 | 15.6K | +0.4% | +$8,228 | |
| 2022-05-20 | 2022-05-18 | DGX | WILENSKY GAIL R | Dir | A - Grant | $0.00 | +1,292 | 19.1K | +7% | $0 | |
| 2022-05-20 | 2022-05-18 | DGX | Lassiter Wright III | Dir | A - Grant | $0.00 | +1,292 | 4,633 | +39% | $0 | |
| 2022-05-20 | 2022-05-18 | DGX | MAIN TIMOTHY L | Dir | A - Grant | $0.00 | +1,292 | 22.2K | +6% | $0 | |
| 2022-05-20 | 2022-05-18 | DGX | Doi Tracey | Dir | A - Grant | $0.00 | +1,292 | 2,209 | +141% | $0 | |
| 2022-05-20 | 2022-05-18 | DGX | MORRISON DENISE M | Dir | A - Grant | $0.00 | +1,292 | 6,540 | +25% | $0 | |
| 2022-05-20 | 2022-05-18 | DGX | RING TIMOTHY M | Dir | A - Grant | $0.00 | +1,292 | 23.9K | +6% | $0 | |
| 2022-05-20 | 2022-05-18 | DGX | DEPPE MICHAEL J | VP, CAO, Corp. Ctrl | F - Tax | $136.98 | -8 | 32.0K | -0.0% | -$1,096 | |
| D | 2022-05-19 | 2022-05-17 | DGX | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $66.51 | +50.6K | 89.8K | +129% | +$3.37M |
| D | 2022-05-19 | 2022-05-17 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale+OE | $139.97 | -50.6K | 39.2K | -56% | -$7.08M |
| 2022-03-09 | 2022-03-07 | DGX | RUSCKOWSKI STEPHEN H | COB, CEO, Pres, Dir | A - Grant | $130.09 | +70.2K | 367.4K | +24% | +$9.13M | |
| 2022-03-09 | 2022-03-07 | DGX | RUSCKOWSKI STEPHEN H | COB, CEO, Pres, Dir | F - Tax | $130.09 | -32.6K | 334.8K | -9% | -$4.24M | |
| 2022-03-09 | 2022-03-07 | DGX | GUINAN MARK | EVP, CFO | A - Grant | $130.09 | +20.8K | 109.5K | +23% | +$2.70M | |
| 2022-03-09 | 2022-03-07 | DGX | GUINAN MARK | EVP, CFO | F - Tax | $130.09 | -10.5K | 99.0K | -10% | -$1.36M | |
| 2022-03-09 | 2022-03-07 | DGX | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $130.09 | +11.5K | 50.8K | +29% | +$1.50M | |
| 2022-03-09 | 2022-03-08 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $135.21 | -6,228 | 39.2K | -14% | -$842.1K | |
| 2022-03-09 | 2022-03-07 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $130.09 | -5,316 | 45.5K | -10% | -$691.6K | |
| 2022-03-09 | 2022-03-07 | DGX | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | A - Grant | $130.09 | +16.2K | 56.3K | +40% | +$2.10M |
Purchase Sale Sale after option exercise All abbreviations